The 3 analysts offering 12-month price forecasts for Moleculin Biotech Inc have a median target of 18.00, with a high estimate of 29.00 and a low estimate of 14.00. The median estimate represents a +358.02% increase from the last price of 3.93.
The current consensus among 3 polled investment analysts is to Buy stock in Moleculin Biotech Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.19
Reporting Date Aug 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.